| Amgen Switzerland AG - Wezenla 45 mg/0.5 ml, Injektionslösung |
| 70189 | | 01 | | Wezenla 45 mg/0.5 ml | | Injektionslösung | | L04AC05 | | Ustekinumab | | 23.07.2025 | | |
|
| Composition |
| ustekinumabum 45 mg, saccharum, histidinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Ustekinumabum | 45mg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Ustekinumabum | 45 mg |
| | | | Inactive agents |
|---|
| Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 1401.06 | 1540.15 | B | SL | No |
|
